Abstract��
By a targeting-delivery system, drugs are delivered and concentrated in a local district such as target tissues, organs, cells or a special district of cells to avoid harm to healthy tissues. Curcumin has various pharmacological activities, but the clinical application of curcumin is severely limited by its main drawbacks including instability, low solubility and poor bioavailability. Recently curcumin-targeting dosage forms which improved the curcumin bioavailability surged. In this article, the new targeting-delivery systems and their use in curcumin delivery mainly including liposomes, ligand-receptors, magnetic iron oxides and other systems are reviewed in design methodologies and bioactive effects. Advantages and disadvantages for the target-delivery systems are discussed.
BI Wen-Jie,
MU Xiao-Jing-*,
Zu-Li-Pi-Yan-��A-Bu-Li-Mi-Te etc
.Progress in Targeting-Delivery Systems for Curcumin[J] Chinese Pharmaceutical Journal, 2015,V50(4): 323-329
��
[1]
MURAI M Y, MEENA J, SUBHASH C C. Curcumin nanomedicine: A road to cancer therapeutics.Curr Pharm Design, 2013,19(11):1994-2010.
[2]
SHARMA R A,GESCHER A J,STEWARD W P, et al. Curcumin: The story so far.Eur J Cancer, 2005,41(13): 1955-1968.
[3]
MOGHDAMTOUSI S Z, KADIR H A, HASSANDARVISH P, et al. A review on antibacterial, antiviral, and antifungal activity of curcumin. Bio Med Res Int, 2014,186864:1-12.
[4]
ZHOU H Y, BEEVERS C S, HUANG S, et al. The targets of curcumin. Curr Drug Targets,2011,12(3):332-347.
[5]
BASNET P, SKALKO B N. Curcumin: An antiinflammatory molecule from a curry spice on the path to cancer treatment. Molecules, 2011,16(6):4567-4598.
[6]
LOPRESTI A L, HOOD S D, DRUMMOND P D. Multiple antidepressant potential modes of action of curcumin: A review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects.J Psychopharmacol, 2012,26(12):1512-1524.
[7]
AGGARWAL B B, YUAN W, LI S Y. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric. Mol Nutr Food Res, 2013,57(9):1529-1542.
[8]
MENG B, LI Y, CAO H. Antioxidant and antiinflammatory activities of curcumin on diabetes mell-itus and its complications. Curr Pharm Design, 2013,19(11):2101-2113.
[9]
KUMAR A, LI L, CHATURVEDI A, et al. Two-photon fluorescence properties of curcumin as a biocompatible marker for confocal imaging. Appl Phys Lett, 2012,100(20):1-4.
[10]
EREZ Y, PRESIADO I, GEPSHTEIN R, et al. Temperature dependence of the fluorescence proper-ties of curcumin. J Phys Chem A , 2011,115(40):10962-10971.
[11]
BENASSI R, FERRARI E, LAZZARI S, et al. How glucosylation triggers physical-chemical prop-erties of curcumin: An experimental and theoretical study. J Phys Org Chem, 2011,24(4):299-310.
[12]
REASON W, MYSORE S V, MARILENE B W, et al. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer ,2011,10(12):1-19.
[13]
LI X Y, CHEN T K, XU L, et al. Preparation of curcumin micelles and the in vitro and in vivo ev-aluation for cancer therapy. J Biomed Nanotechnol, 2014,10(8):1458-1468.
[14]
SAMPATH M, LAKRA R, KORRAPATI P, et al. Curcumin loaded poly (lactic-co-glycolic) acid nanofiber for the treatment of carcinoma. Colloid Surf B, 2014,117(5): 128-134.
[15]
LIN C C, LIN H Y, CHI M H, et al. Preparation of curcumin microemulsions with food-grade soyb-ean oil/lecithin and their cytotoxicity on the HepG2 cell line. Food Chem, 2014,154(1):282-290.
[16]
RATANAVARAPORN J, KANOKPANONT S, DAMRONGSAKKUL S. The development of inje-ctable gelatin/silk fibroin microspheres for the dual delivery of curcuminand piperine. J Mater Sci :Mater Med, 2014,25(2):401-410.
[17]
RAO W, ZHANG W J, POVENTUD-FUENTES I, et al. Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction. Acta Biomater, 2014,10(2):831-842.
[18]
SEETA RAMA RAJU G, PAVITRA E, GANJI P N, et al. Imaging and curcumin delivery in pancreatic cancer cell lines using PEGylated α-Gd2(MoO4)3 mesoporous particles. Dalton Trans, 2014,43(8):3330-3338.
[19]
NAKSURIYA O, OKONGI S, SCHIFFELERS R M, et al. Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.Biomaterials, 2014,35(10):3365-3383.
[20]
SALEM M, ROHAMI S, GILLIES E R. Curcumin, a promising anti-cancer therapeutic: A review of its chemical properties, bioactivity and approaches to cancer cell delivery. Rsc Adv, 2014,4(21):10815-10829.
[21]
CHEN Q Y, ZHENG Y, JIAO D M, et al. Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway. J Nutr Biochem, 2014,25(2):177-185.
[22]
LIM T G, LEE S Y, HUANG Z N, et al. Curcumin suppresses proliferation of colon cancer cells by targeting CDK2. Cancer Prev Res, 2014,7(4):466-474.
[23]
KRONSKI E, FIORI M E, BARBIERI O, et al. MiR181b is induced by the chemopreventive poly-phenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and-2. Mol Oncol, 2014,8(3):581-595.
[24]
CAI X Z, HUANG W Y, QIAO Y. Inhibitory effects of curcumin on gastric cancer cells: A proteo-mic study of molecular targets. Phytomedicine, 2013,20(6):495-505.
[25]
CHIANG I T, LIU Y C, HSU F T, et al. Curcumin synergistically enhances the radiosensitivity of human oral squamous cell carcinoma via suppression of radiation-induced NF-kappa B activity.Oncol Rep, 2014,31(4):1729-1737.
[26]
SLUSARZ A, SHENOUDA N S, SAKLA M S, et al. Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res, 2010,70(8):3382-3390.
[27]
SUN X D, LIU X E, HUANG X S. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway. Oncol Rep, 2013,29(6):2401-2407.
[28]
HE M S, LI Y, ZHANG L, et al. Curcumin suppresses cell proliferation through inhibition of the Wnt/beta-catenin signaling pathway in medulloblastoma. Oncol Rep, 2014,32(1):173-180.
[29]
SUBRAMANIAM D, PONURANGAM S, RAMAMOORTHY P. Curcumin induces cell death in esophageal cancer cells through modulating notch signaling. Plos One, 2012,7(2):1-11.
[30]
GAO W, CHAN J Y W, WEI W I, et al. Anti-cancer effects of curcumin on head and neck cancers. Anticancer Agents Med Chem, 2012,12(9):1110-1116.
[31]
PHYLLIS L, PRIYA R D, JOSEPH D R I, et al. Coupling to a glioblastoma-directed antibody po-tentiates antitumor activity of curcumin. Int J Cancer, 2014,135( 3 ):710-719.
[32]
AJAZUDDIN, SARAF S. Applications of novel drug delivery system for herbal formulations. Fitoterapia, 2010,81(7):680-689.
[33]
WANG D, VEENA M S, STEVENSON K, et al. Liposome-encapsulated curcumin suppresses gro-wth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor κb by an akt-independent pathway. Clin Cancer Res, 2008,14(19):6228-6236.
[34]
HASAN M, BELHAJ N, BENACHOUR H, et al. Liposome encapsulation of curcumin: Physico-chemical characterizations and effects on MCF7 cancer cell proliferation. Int J Pharm,2014,461(1-2):519-528.
[35]
VITAGLIONE P, LUMAGA R B, FERRACANE R, et al. Curcumin bioavailability from enriched bread: The effect of microencapsulated ingredients. J Agric Food Chem, 2012,60(13):3357-3366.
[36]
LI C, ZHANG X L, HUANG X L, et al. Preparation and characterization of flexible nanoliposomes loaded with daptomycin, a novel antibiotic, for topical skin therapy. Int J Nanomed, 2013,8(3):1285-1292.
[37]
LI C, ZHANG Y, SU T T, et al. Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin. Int J Nanomed, 2012,7(12):5995-6002.
[38]
SAENGKRIT N, SAESOO S, SRINUANCHAI W, et al. Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy. Collodis Surf B, 2014,114(10):349-356.
[39]
DHULE S S, PENFORNIS P, FRAZIER T, et al. Curcumin-loaded gamma-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomed-Nanotechnol Biol Med, 2012,8(4):440-451.
[40]
NIU Y M, DAN K, YANG Q Q, et al. Temperature-dependent stability and DPPH scavenging acti-vity of liposomal curcumin at pH 7.0. Food Chem,2012,135(3):1377-1382.
[41]
LAZAR A N, MOURTAS S, YOUSSEF I, et al. Curcumin-conjugated nanoliposomes with high affinity for A beta deposits: Possible applications to Alzheimer disease. J Nano, 2012,9(5): 712-721.
[42]
LU Y, DING N, YANG C, et al. Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation. J Liposome Res, 2012,22( 2): 110-119.
[43]
CHU Y, LI D, LUO Y F, et al. Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers. Molecules, 2014,19(2):2445-2457.
[44]
GUGULOTHU D, KULKARNI A, PATRAVALE V, et al. pH-sensitive nanoparticles of curcumin-celecoxib combination: Evaluating drug synergy in ulcerative colitis model. J Pharm Sci,2014,103(2):687-696.
[45]
DAVARAN S, ALIMIRZALU S, NEJATI-KOSHKI K, et al. Physicochemical characteristics of Fe3O4 magnetic nanocomposites based onpoly(N-isopropylacrylamide) for anti-cancer drug deliv-ery. Asian Pac J Cancer P, 2014,15(1):49-54.
[46]
ABOUZEID A H, PATEL N R, RACHMAN I M, et al. Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcuminand doxorubicin. J Drug Targeting,2013,21(10):994-1000.
[47]
BARUI S, SAHA S, MONDAL G, et al. Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of PEGylated RGDK-lipopeptide to tumor vasculature. Biomaterials, 2014,35(5): 1643-1656.
[48]
FANG Y. Ligand-receptor interaction platforms and their applications for drug discovery. Expert Opin Drug Dis, 2012,7(10): 969-988.
[49]
DANIELS T R, BERNABEU E, RODRIGUEZ J A, et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. BBA-Gen Subjects, 2012,1820(3):291-317.
[50]
MULIK R S, MONKKONEN J, JUVONEN R O, et al. Transferrin mediated solid lipid nanoparticles containing curcumin: Enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm, 2010,398(1-2):190-203.
[51]
GANDAPU U, CHAITANYA R K, KISHORE G, et al. Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro. Plos One, 2011,6(8):1-11.
[52]
PIRES L A, HEGG R, FREITAS F R, et al. Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advan ced breast cancer. Braz J Med Biol Res, 2012,45(6):557-564.
[53]
PANUPON K, RICARDO R, DARIN K, et al. Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein:A nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid. Biochimica Et Biophysica Acta, 2011,18(8): 352-359.
[54]
DAS M K,HUSAIN K, PATHAK Y, et al. Brain targeted delivery of curcumin using P80-PEG-coated poly(lactide-co-glycolide) nanoparticles. Asian J Chem, 2013,25(S1): 297-301.
[55]
ZHANG L, ZHU W W, YANG C F, et al. A novel folate-modified self-microemulsifying drug deli-very system of curcumin for colon targeting. Int J Nanomed, 2012,7(1):151-162.
[56]
MAITY A R, CHAKRABORTY A, MONDAL A, et al. Carbohydrate coated, folate functionalized colloidal graphene as a nanocarrier for bothhydrophobic and hydrophilic drugs. Nanoscale, 2014, 6(5): 2752-2758.
[57]
KHATIK R, DWIVEDI P, UPADHYAY M, et al. Toxicological evaluation and targeting tumor cells through folic acid modified Guar Gum nanoparticles of curcumin. J Biomater Tiss Eng, 2014, 4(2): 143-149.
[58]
D′SOUZA A A, JAIN P, GALDHAR C N, et al. Comparative in Silico-in vivo evaluation of ASGP-R ligands for hepatic targeting of curcumin Gantrez nanoparticles. AAPS J ,2013,15(3):696-706.
[59]
LOPEA A F, HERCUS T R, EKERT P, et al. Molecular basis of cytokine receptor activation.IUBMB Life,2010,62(7): 509-518.
[60]
SAMAH D, KARSTEN H, CLAIRE R. Autophosphorylation activation and inhibition by curcumin of the epidermal growth factor receptor reconstituted in liposomes. J Mol Recognit, 2012,25(11):623-629.
[61]
KUMAR A, DAS G, BODE B. Recombinant receptor-binding domain of diphtheria toxin increases the potency of curcumin by enhancing cellular uptake. Mol Pharm, 2014,11(1):208-217.
[62]
MONDAL G, BARUI S, SAHA S, et al. Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature. J Controlled Release, 2013,172(3):832-840.
[63]
ANGELA C, ENRIQUE B C, SILVIA N, et al. Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells. Breast Cancer Res Treat, 2013,141(1):55-65.
[64]
SUN S G, ZHUANG X Y, XIANG X Y, et al. A novel nanoparticle drug delivery system: The anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther,2010,18(9):1606-1614.
[65]
AGGARWAL S, NDINGURI M W, SOLIPURAM R, et al. DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo. Int J Cancer, 2011,129(7):1611-1623.
[66]
WEI X, SENANAYAKE T H, WARREN G, et al. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors. Bioconjugate Chem, 2013,24(4): 658-668.
[67]
LIU J F, LIU J J, XU H Y, et al. Novel tumor-targeting, self-assembling peptide nanofiber as a carri-er for effective curcumin delivery. Int J Nanomed, 2014,9(1):197-207.
[68]
YALLAPU M M, OTHMAN S F, CURTIS E T. Multi-functional magnetic nanoparticles for magn-etic resonance imaging and cancer therapy. Biomaterials, 2011,32(7): 1890-1905.
[69]
YALLAPU M M, OTHMAN S F, CURTIS E T, et al. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomed, 2012,7(4):1761-1779.
[70]
LU W S, SHEN Y H, XIE A J, et al. Preparation and drug-loading properties of Fe3O4/Poly(styrene-co-acrylic acid) magnetic polymer nanocomposites. J Magn Magn Mater, 2013,345:142-146.
[71]
LAM D T, HOANG N M T, TRANG T M, et al. Nanosized magnetofluorescent Fe3O4-curcumin conjugate for multimodal monitoring and drug targeting. Colloids Surf A, 2010,371(1-3):104-112.
[72]
WANG Q J, LIU R J, SHEN X Q, et al. Mesoporous iron oxide nanofibers and their loading capa-city of curcumin. J Nanosci Nanotechno, 2014,14(4): 2871-2877.
[73]
ANWER M, ASFER M, PRAJAPATI A P, et al. Synthesis and in vitro localization study of curcu min-loaded SPIONs in a micro capillary for simulating a targeted drug delivery system . Int J Pharm, 2014,468(1-2):158-164.
[74]
YALLAPU M M, MAHER D M, SUNDRAM V, et al. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res, 2010,3(11):1-12.
[75]
LI L, XIANG D G, SHIGDAR S, et al. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adeno-carcinoma cells. Int J Nanomed, 2014,9(1): 1083-1096.
[76]
WANG Y M, SUN Y, WANG H, et al. Synthesis of low-molecular weight protein (LMWP) lysozy-me-curcumin conjugates for kidney drug targeting. J Biomater Sci Polym Ed, 2013,24(11):1360-1367.
[77]
KHATIK R, MISHRA R, VERMA A, et al. Colon-specific delivery of curcumin by exploiting Eud ragit-decorated chitosan nanoparticles in vitro and in vivo. J Nanopart Res, 2013,15(9):1893-1908.
[78]
YU Y, ZHANG X L, QIU L Y, et al. The anti-tumor efficacy of curcumin when delivered by size/charge changing multistage polymeric micelles based on amphiphilic poly(baminoester) derivates.Biomaterials, 2014,35(10):3467-3479.
[79]
JI G J, YANG J H, CHEN J H, et al. Preparation of novel curcumin-loaded multifunctional nanodro plets for combining ultrasonic development and targeted chemotherapy. Int J Pharm, 2014,466(1-2):314-320.
2015, Vol. 50 
